143 related articles for article (PubMed ID: 22605609)
1. Topical dobesilate eye drops for ophthalmic primary pterygium.
Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605609
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin eye drops as treatment for pterygium.
Singh G; Wilson MR; Foster CS
Ophthalmology; 1988 Jun; 95(6):813-21. PubMed ID: 3211484
[TBL] [Abstract][Full Text] [Related]
3. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
Kasetsuwan N; Reinprayoon U; Satitpitakul V
Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
[TBL] [Abstract][Full Text] [Related]
4. Dobesilate in the treatment of plaque psoriasis.
Cuevas P; Arrazola JM
Eur J Med Res; 2005 Sep; 10(9):373-6. PubMed ID: 16183548
[TBL] [Abstract][Full Text] [Related]
5. Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.
Wu PC; Kuo HK; Tai MH; Shin SJ
Cornea; 2009 Jan; 28(1):103-4. PubMed ID: 19092418
[TBL] [Abstract][Full Text] [Related]
6. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.
Frucht-Pery J; Siganos CS; Solomon A; Shvartzenberg T; Richard C; Trinquand C
Am J Ophthalmol; 1999 Feb; 127(2):148-52. PubMed ID: 10030555
[TBL] [Abstract][Full Text] [Related]
7. [Antiangiogenic therapy for pterygium recurrence].
Leippi S; Grehn F; Geerling G
Ophthalmologe; 2009 May; 106(5):413-9. PubMed ID: 19418056
[TBL] [Abstract][Full Text] [Related]
8. Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
Fonseca EC; Rocha EM; Arruda GV
Br J Ophthalmol; 2018 Jun; 102(6):748-756. PubMed ID: 29146761
[TBL] [Abstract][Full Text] [Related]
9. Treatment of basal cell carcinoma with dobesilate.
Cuevas P; Arrazola JM
J Am Acad Dermatol; 2005 Sep; 53(3):526-7. PubMed ID: 16112368
[No Abstract] [Full Text] [Related]
10. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.
Rachmiel R; Leiba H; Levartovsky S
Br J Ophthalmol; 1995 Mar; 79(3):233-6. PubMed ID: 7703200
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study.
Motarjemizadeh Q; Aidenloo NS; Sepehri S
Int Ophthalmol; 2016 Feb; 36(1):63-71. PubMed ID: 25943172
[TBL] [Abstract][Full Text] [Related]
12. The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial.
Schram MT; Stam F; de Jongh RT; de Vries G; van Dijk RA; Serné EH; Lampe D; Nanayakkara PW; Tushuizen ME; Scheffer PG; Schalkwijk CG; Kamper AM; Stehouwer CD
Atherosclerosis; 2003 Sep; 170(1):59-72. PubMed ID: 12957683
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium.
Helal M; Messiha N; Amayem A; el-Maghraby A; Elsherif Z; Dabees M
Ophthalmic Surg Lasers; 1996 Aug; 27(8):674-8. PubMed ID: 8858633
[TBL] [Abstract][Full Text] [Related]
14. Calcium dobesilate may improve hemorheology in patients undergoing coronary artery bypass grafting.
Besirli K; Aydemir B; Arslan C; Kiziler AR; Canturk E; Kayhan B
Rev Bras Cir Cardiovasc; 2012; 27(2):260-6. PubMed ID: 22996977
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Stargardt disease with dobesilate.
Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
BMJ Case Rep; 2012 Oct; 2012():. PubMed ID: 23076703
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of calcium dobesilate in treating acute attacks of hemorrhoidal disease.
Menteş BB; Görgül A; Tatlicioğlu E; Ayoğlu F; Unal S
Dis Colon Rectum; 2001 Oct; 44(10):1489-95. PubMed ID: 11598479
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation.
Singh G; Wilson MR; Foster CS
Cornea; 1990 Oct; 9(4):331-4. PubMed ID: 2078962
[TBL] [Abstract][Full Text] [Related]
18. Calcium dobesilate for chronic venous insufficiency: a systematic review.
Ciapponi A; Laffaire E; Roqué M
Angiology; 2004; 55(2):147-54. PubMed ID: 15026869
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease.
Martínez-Zapata MJ; Moreno RM; Gich I; Urrútia G; Bonfill X;
Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):358-65. PubMed ID: 17962050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
